Watch Demo

Italy Anti-Infective Industry Outlook 2022 - 2026

See how Italy Anti-Infective performed compared to key markets such as the United Kingdom, Germany and South Korea.

Key Market Indicators

The country was number 4 in 2021, South Korea came ahead with $1,507,700,000. South Korea, Germany and Italy respectively came in numbers 2, 3 and 4 in this ranking. Sales of Italian antiinfective medicine is set to drop 1.4% annually on average and decline 9% since 2016. In 2021, Italy ranked fourth with sales of $3 billion. South Korea was the leading market, followed by Germany and Italy. Italian exports of antibiotics are expected to rise 1% annually on average and increase 2.6% since 1999. Switzerland topped the list in 2021 with exports of $1.01 billion. Switzerland, Italy and India ranked second, third and fourth, respectively. Italian imports of antibiotics are forecast to grow 0.1% annually on average and increase 0.1% since 1999. South Korea was the leader in 2021 with imports of $1.51 billion. South Korea, Germany and Italy were second, third and fourth, respectively.

Italy Anti-Infective Market Data and Forecasts

What is the size of the Italian Anti-Infective Market in 2022?

Penicillins and Streptomycins in Dosage Market Size Value in Italy
Penicillins and Streptomycins in Dosage Market Size Value Per Capita in Italy
More in Anti-Infective Industry in major countries

How much will Italy Anti-Infective Market grow to 2026?

Forecast: Antiinfective Medicine Sales in Italy
Forecast: Antiinfective Medicine Sales in Italy
Forecast: Antiinfective Medicine Sales in Italy
More in Anti-Infective Industry for 2027

Purchase Reports from Reputable Market Research Publishers